These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15630040)

  • 1. Drug therapy in the heart transplant recipient: Part III: common medical problems.
    Lindenfeld J; Page RL; Zolty R; Shakar SF; Levi M; Lowes B; Wolfel EE; Miller GG
    Circulation; 2005 Jan; 111(1):113-7. PubMed ID: 15630040
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy in the heart transplant recipient: part IV: drug-drug interactions.
    Page RL; Miller GG; Lindenfeld J
    Circulation; 2005 Jan; 111(2):230-9. PubMed ID: 15657387
    [No Abstract]   [Full Text] [Related]  

  • 3. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Integrated drug therapy of the metabolic syndrome].
    Julius U; Hanefeld M
    Internist (Berl); 1996 Jul; 37(7):722-30. PubMed ID: 8766266
    [No Abstract]   [Full Text] [Related]  

  • 5. Association between age and the initiation of antihypertensive, lipid lowering and antiplateletet medications in elderly individuals newly treated with antidiabetic drugs.
    Sirois C; Moisan J; Poirier P; Couture J; Gregoire JP
    Age Ageing; 2009 Nov; 38(6):741-5. PubMed ID: 19759258
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory issues in the approval of new drugs for diabetes mellitus, dyslipidemia, and the metabolic syndrome.
    Isaacsohn JL; Troendle AJ; Orloff DG
    Am J Cardiol; 2004 Jun; 93(11A):49C-52C. PubMed ID: 15178516
    [No Abstract]   [Full Text] [Related]  

  • 7. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug update: 2011.
    Hussar DA
    Consult Pharm; 2012 Apr; 27(4):224-37. PubMed ID: 22498984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential of combined hypoglycemic, antihypertensive, and hypolipidemic therapy in patients with diabetes mellitus and diabetic foot syndrome].
    Onuchin SG; Elsukova OS; Onuchina EL
    Klin Med (Mosk); 2008; 86(8):61-6. PubMed ID: 18819351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons.
    Rehring TF; Stolcpart RS; Hollis HW;
    J Vasc Surg; 2008 May; 47(5):1108-15. PubMed ID: 18372155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines of the Spanish Society of Nephrology: the kidney and cardiovascular disease. Short version].
    Marín R; Goicoechea MA; Gorostidi M; Cases A; Díez J; Escolar G; Fernández-Vega F; Palomar R; Rodrigo E; Martínez I; Segura J;
    Nefrologia; 2006; 26(1):31-44. PubMed ID: 16649424
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertension after heart transplantation: predictive factors and number and classes of drugs for its management.
    Sánchez Lázaro IJ; Almenar Bonet L; Martínez-Dolz L; Moro López J; Ramón-Llín JA; Pérez OC; Soriano JR; Fuentes FB; Manchón JN; Sánchez Gómez JM; Sanz AS
    Transplant Proc; 2008 Nov; 40(9):3051-2. PubMed ID: 19010190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication considerations for patients with chronic kidney disease who are not yet on dialysis.
    Liles AM
    Nephrol Nurs J; 2011; 38(3):263-70. PubMed ID: 21877459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gout, bradycardia, and hypercholesterolemia after renal transplantation.
    Kelleher SP; Davis WR; Paraskevopoulos N
    South Med J; 2001 Jul; 94(7):732-4. PubMed ID: 11531183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive and lipid lowering treatment in stroke prevention: current state and future.
    Piechowski-Jóźwiak B; Bogousslavsky J
    Acta Neurol Belg; 2005 Jun; 105(2):57-61. PubMed ID: 16076057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALL predictable, and no big surprise out of a HAT?
    Beevers DG; Lee KW; Lip GY
    J Hum Hypertens; 2003 Jun; 17(6):367-72. PubMed ID: 12764397
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diabetes mellitus and cerebrovascular disorders].
    Udaka F
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():336-41. PubMed ID: 12430250
    [No Abstract]   [Full Text] [Related]  

  • 18. Managing risk factors for atherosclerosis in critical limb ischaemia.
    Gottsäter A
    Eur J Vasc Endovasc Surg; 2006 Nov; 32(5):478-83. PubMed ID: 16631394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacotherapeutical features of arterial hypertension in patients with diabetes mellitus].
    Okunevich IV; Khnychenko LK; Sapronov NS
    Klin Med (Mosk); 2007; 85(1):52-7. PubMed ID: 17419357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.